Patent litigation for adalimumab resolved in the US
24 May 2019 | By European Pharmaceutical Review
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
List view / Grid view
Biopharmaceuticals
Emerging NMR techniques as advanced tools for characterising biological parenteral products
20 May 2019 | By Bruce Yu - University of Maryland School of Pharmacy, Wei Xu - Merck & Co, Yongchao Su - Merck & Co
An important step in the research and development of biopharmaceuticals is to identify molecules with favourable physical and chemical stability profiles. Yongchao Su, Wei Xu and Bruce Yu discuss how solution, solid-state and benchtop nuclear magnetic resonance (NMR) methods can provide advanced biophysical characterisations of biological products.
Market for single-use bioprocessing systems in Asia Pacific rises
17 May 2019 | By European Pharmaceutical Review
The single-use bioprocessing systems market in Asia Pacific has witnessed an impressive rise and is expected to continue growing.
Nelson Labs: supporting internal quality processes
14 May 2019 | By Nelson Labs
Nelson Labs has a long history of partnering with pharmaceutical and biopharmaceutical companies. We perform a variety of testing to support your internal quality processes including: sterility (USP 71) testing in a cleanroom for isolator environment, particulates testing (USP 787, 788) using a variety of methods, bacterial endotoxin, filter validations,…
Routine mass analysis enables greater productivity in biopharma development
13 May 2019 | By Mike Wilson - Director Product Marketing Mass Spectrometry Systems
Biopharma developers and manufacturers need to know their molecules and understand their manufacturing processes better than ever before. In this article, Mike Wilson discusses the benefits of mass analysis in biopharma and the current challenges of adopting new technologies.
Eurofins BioPharma Product Testing
10 May 2019 | By Eurofins
From starting materials through to finished product testing, Eurofins BioPharma Product Testing’s 34 facilities in 17 countries deliver a comprehensive scope of harmonised GMP testing services and seamless regulatory acceptance.
Sartorius Stedim Biotech introduces new SIMCA® 16 software for multivariate data analytics
8 May 2019 | By Sartorius
Leading international partner to the biopharmaceutical industry Sartorius Stedim Biotech (SSB) has today announced that the new SIMCA® 16 software for multivariate data analytics is available from its subsidiary Sartorius Stedim Data Analytics.
Wickham Laboratories Ltd: backed by five decades of global experience
8 May 2019 | By Wickham Laboratories
Wickham Laboratories Ltd, backed by five decades of global experience in GMP/GLP-regulated laboratory services, is an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy.
Expert View: Advancing bacterial endotoxin testing with recombinant Factor C
7 May 2019 | By Karolina Heed - Global Solution Manager Endotoxins at bioMérieux
Emerging recombinant Factor C (rFC) methods have many advantages to offer pharmaceutical quality control, including improved specificity, robustness, efficiency and alignment with 3R principles. First, global manufacturers have validated rFC and pharmacopoeias worldwide are on the move. Here, Karolina Heed provides an industry and regulatory update.
Whitepaper: ENDOZYME II GO recombinant Factor C assay: fast, easy and consistent endotoxin testing
7 May 2019 | By Hyglos-bioMerieux
Microplate-based standard endotoxin tests require time-consuming manual handling steps, the results of which are by no means conclusive. Read how the GO PLATE - part of ENDOZYME II GO - helps to address these issues.
Taking the difficulty out of API process filtration
26 April 2019 | By Amazon Filters Ltd.
Amazon Filters has selected the Making Pharmaceuticals Exhibition & Conference 2019 to showcase its latest filter housings and microfiltration filter cartridges, which are used in the manufacture of Active Pharmaceutical Ingredients (API) and are the essential components when creating pharmaceutical products.
Biopharma Processing & Development In-Depth Focus 2019
26 April 2019 | By European Pharmaceutical Review
Today’s biopharmaceutical developers need accurate and precise information at all stages of research and development in order to bring safe and effective therapies to patients. This in-depth focus features novel perspectives from industry experts that serve to illustrate which technologies and systems are benefitting this cause.
Formulation In-Depth Focus 2019
26 April 2019 | By European Pharmaceutical Review
As today’s scientists continue to identify new biopharmaceutical products with potential to treat a wide array of diseases, formulation remains the determining factor in their success. But what is involved in these increasingly complex formulation processes and how do they impact the packaging and delivery systems?
European Pharmaceutical Review Issue 2 2019
25 April 2019 | By European Pharmaceutical Review
This issue questions whether companies are sufficiently investing in regulatory intelligence software and what the potential consequences of Brexit might be for locations outside of the UK and EU. The issue also features articles on microbiology, formulation and biopharma, courtesy of our in-depth focus sections; as well as outlining the…
Prometic Bioseparations introduces GMP-ready columns
15 March 2019 | By Prometic Bioseparations
An introduction to Prometic Bioseparations based in Cambridge. For over 30 years the company has provided innovative purification solutions to the Biopharmaceutical industry.
Follow: